United States - Export of Vaccines for Human Use
Since 2014, United States Export of Vaccines for Human Use decreased by 2.3% year on year. In 2019, the country was number 5 among other countries in Export of Vaccines for Human Use with $2,174,358,179.98. United States is overtaken by France, which was number 4 with $3,729,128,821.59 and is followed by Italy at $1,037,917,606.59. Belgium lead the ranking with $6,511,782,808.63 in 2019, that is an increase of 2.7% versus 2018. Nicaragua recorded the best 5 years average growth at +356.4% per year, while Dominican Republic witnessed the worst performance at -87.1% per year.
Loading...
Date | US Dollars |
---|---|
2019 | 2,174,358,179.98 |
2018 | 2,364,216,320.00 |
2017 | 1,419,080,576.00 |
2016 | 1,826,365,184.00 |
2015 | 2,926,207,232.00 |
Download all data from 1991 to 2019
How does United States rank in Export of Vaccines for Human Use?
# | 115 Countries | US Dollars | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
Belgium
|
6,511,782,808.63 | 2019 | +2.7 % | -9.2 % | View data | |
2 |
#2
Ireland
|
5,792,918,864.55 | 2019 | -0.9 % | +16.3 % | View data | |
4 |
#4
France
|
3,729,128,821.59 | 2019 | -2.0 % | -6.0 % | View data | |
5 |
#5
United States
|
2,174,358,179.98 | 2019 | -8.0 % | -2.3 % | View data | |
6 |
#6
Italy
|
1,037,917,606.59 | 2019 | +12.1 % | +6.8 % | View data |